Relationship Between Adipocyte Size and Adipokine Expression and Secretion
Overview
Affiliations
Context: Adipocytes are known to release a variety of factors that may contribute to the proinflammatory state characteristic for obesity. This secretory function is considered to provide the basis for obesity-related complications such as type 2 diabetes and atherosclerosis.
Objective: To get a better insight into possible underlying mechanisms, we investigated the effect of adipocyte size on adipokine production and secretion.
Design, Patients, And Main Outcome Measures: Protein secretion and mRNA expression in cultured adipocytes separated according to cell size from 30 individuals undergoing elective plastic surgery were investigated.
Results: The mean adipocyte volume of the four fractions ranged from 205 +/- 146 to 1.077 +/- 471 pl. There were strong linear correlations for the secretion of adipokines over time. Secretion of leptin, IL-6, IL-8, TNF-alpha, monocyte chemoattractant protein-1, interferon-gamma-inducible protein 10, macrophage inflammatory protein-1beta, granulocyte colony stimulating factor, IL-1ra, and adiponectin was positively correlated with cell size. After correction for cell surface, there was still a significant difference between fraction IV (very large) and fraction I (small cells), for leptin, IL-6, IL-8, monocyte chemoattractant protein-1, and granulocyte colony-stimulating factor. In contrast, antiinflammatory factors such as IL-1ra and adiponectin lost their association after correction for cell surface area comparing fraction I and IV. In addition, there was a decrease of IL-10 secretion with increasing cell size.
Conclusions: The results clearly suggest that adipocyte size is an important determinant of adipokine secretion. There seems to be a differential expression of pro- and antiinflammatory factors with increasing adipocyte size resulting in a shift toward dominance of proinflammatory adipokines largely as a result of a dysregulation of hypertrophic, very large cells.
Binge Eating Disorder and Metabolic Syndrome: Shared Mechanisms and Clinical Implications.
Alagha M, Al-Alam F, Saroufine K, Elias L, Klaimi M, Nabbout G Healthcare (Basel). 2025; 13(5).
PMID: 40077044 PMC: 11898466. DOI: 10.3390/healthcare13050482.
Galigniana N, Abdelhalim M, Collas P, Saether T Nutrients. 2025; 16(24.
PMID: 39770930 PMC: 11676188. DOI: 10.3390/nu16244310.
Effect of Diet on HDL in Obesity.
Bacchetti T, Morresi C, Simonetti O, Ferretti G Molecules. 2025; 29(24.
PMID: 39770044 PMC: 11677490. DOI: 10.3390/molecules29245955.
Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health.
Lecoutre S, Rebiere C, Maqdasy S, Lambert M, Dussaud S, Abatan J Nat Rev Endocrinol. 2025; .
PMID: 39757324 DOI: 10.1038/s41574-024-01071-y.
Luk C, Bridge K, Warmke N, Simmons K, Drozd M, Moran A Nat Commun. 2025; 16(1):170.
PMID: 39747815 PMC: 11696296. DOI: 10.1038/s41467-024-54669-1.